ChemoMetec A/S (CPH:CHEMM)
Denmark · Delayed Price · Currency is DKK 515.00
-10.00 (-1.90%)
Sep 25, 2026, 4:59 PM CET
ChemoMetec Market Cap
ChemoMetec has a market cap or net worth of 8.86 billion as of September 25, 2026. Its market cap has decreased by -20.28% in one year.
Market Cap
8.86B
Enterprise Value
8.57B
Revenue
511.06M
Ranking
n/a
PE Ratio
44.40
Stock Price
515.00
ChartMarket Cap Chart
Since December 18, 2006, ChemoMetec's market cap has increased from 374.48M to 8.86B, an increase of 2,265.51%. That is a compound annual growth rate of 17.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 8.86B | -25.96% |
| Dec 30, 2025 | 11.96B | 41.40% |
| Dec 30, 2024 | 8.46B | 25.31% |
| Dec 29, 2023 | 6.75B | -43.81% |
| Dec 30, 2022 | 12.02B | -17.11% |
| Dec 30, 2021 | 14.50B | 44.12% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.12T |
| Genmab | 136.06B |
| Coloplast | 94.03B |
| Demant | 64.79B |
| ALK-Abelló | 44.31B |
| Zealand Pharma | 18.57B |
| Ambu A/S | 17.80B |
| Bavarian Nordic | 16.49B |